CAS 60548-08-5
:4-Quinazolinamina, 6,7-dimetoxi-2-(1-piperazinil)-, dihidrocloruro
Terazosin Related Compound A (6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C14H19N5O2·2HClForma y color:White PowderPeso molecular:289.153876,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride
CAS:6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloridePureza:97%Peso molecular:362.26g/molN-Des((tetrahydrofuran-2-yl)methanone)) Terazosin Dihydrochloride
CAS:Producto controladoApplications N-Des((tetrahydrofuran-2-yl)methanone)) Terazosin Dihydrochloride is a related compound to Terazosin (T105000), a α-1-adrenergic blocker related to Prazosin (P702325).
References Patterson, S.E., et al.: J. Chromatog., 311, 206 (1984), Fort, F.L., et al.: Drug Chem. Toxicol., 7, 435 (1984), Lepor, H., et al.: J. Urol., 148, 1467 (1992),Fórmula:C14H19N5O2HClForma y color:NeatPeso molecular:362.256,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride
CAS:6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride (DMPQ) is a piperazine derivative that is a potent and selective inhibitor of phosphodiesterase type 5 (PDE5). This drug has been shown to be useful in the treatment of the symptoms of benign prostatic hyperplasia. DMPQ inhibits the hydrolysis of cyclic adenosine monophosphate (cAMP), which leads to an increase in intracellular levels of cAMP. This drug also exhibits antihypertensive effects, as it inhibits the activity of nitric oxide synthase.
Fórmula:C14H21Cl2N5O2Pureza:Min. 95%Peso molecular:362.3 g/mol





